|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net increase (decrease) in net assets resulting from operations | ||||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | ||||
| Realized loss on extinguishment of debt | ||||
| Net realized (gain) loss | ||||
| Change in net unrealized (appreciation) depreciation of investments | ||||
| Net amortization of investment discounts and premiums | ||||
| Amortization of original issue discount on debt | ||||
| Interest and dividend income paid in kind | ||||
| Amortization of deferred debt issuance costs | ||||
| Cash acquired in the Merger | ||||
| Merger costs capitalized into purchase price | ||||
| Changes in assets and liabilities: | ||||
| Purchases of investments | ||||
| Proceeds from disposition of investments | ||||
| Decrease (increase) in interest, dividends and fees receivable | ||||
| Decrease (increase) in due from broker | ||||
| Decrease (increase) in receivable for investments sold | ||||
| Decrease (increase) in prepaid expenses and other assets | ||||
| Increase (decrease) in payable for investments purchased | ||||
| Increase (decrease) in incentive fees payable | ||||
| Increase (decrease) in interest and debt related payables | ||||
| Increase (decrease) in Interest Rate Swap, at fair value | ||||
| Increase (decrease) in reimbursements due to the Advisor | ||||
| Increase (decrease) in management fees payable | ||||
| Increase (decrease) in accrued expenses and other liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Financing activities | ||||
| Draws on credit facilities | ||||
| Repayments of credit facility draws | ||||
| Payments of debt issuance costs | ||||
| Dividends paid to shareholders | ||||
| Repurchase of shares | ||||
| Repayment of convertible notes | ||||
| Repayment of unsecured notes | ||||
| Proceeds from issuance of unsecured notes | ||||
| Net cash provided by (used in) financing activities | ||||
| Net increase (decrease) in cash and cash equivalents (including restricted cash) | ||||
| Cash and cash equivalents (including restricted cash) at beginning of period | ||||
| Cash and cash equivalents (including restricted cash) at end of period | ||||
| Supplemental cash flow information | ||||
| Interest payments | ||||
| Excise tax payments | ||||
| Distributions Payable | ||||
| Non-cash operating and financing activities from the Merger | ||||
| Non-cash assets acquired: | ||||
| Investments | ||||
| Interest, dividends and fees receivable | ||||
| Due from broker | ||||
| Other assets | ||||
| Total non-cash assets acquired | ||||
| Liabilities assumed: | ||||
| Debt | ||||
| Dividends payable | ||||
| Management fees payable | ||||
| Interest Rate Swap, at fair value | ||||
| Incentive fees payable | ||||
| Other liabilities | ||||
| Total liabilities assumed | ||||
| Issuance of shares in connection with the Merger | ||||
| Merger costs capitalized into purchase price |
Loading...
